Flu Vaccine

A study on the efficacy of a vaccine against influenza in adults ≥65 years of age. There is no placebo in this trial all participants will receive the investigational flu or the comparator. The intended duration of the study, per participant, is approximately 6 to 8 months, from the day of dosing until the end of the corresponding influenza season (with at least 180 days of follow-up). The required visits to the clinic will be 3 and 1 telephone call. No cost for participation and compensation up t $325 will be provided for time and travel expenses.